Fred Schulte

After several rounds of treatment for a rare eye cancer—weekly drug infusions that could cost nearly $50,000 each—Paul ...

Dr. Kingsley R. Chin was little more than a decade out of Harvard Medical School when the sales ...

When President Donald Trump started touting hydroxychloroquine as “one of the biggest game changers” for treating COVID-19, researchers ...

Derek Lewis was working as an electronic health records specialist for the nation’s largest hospital chain when he ...

Two decades ago, Purdue Pharma produced thousands of brochures and videos that urged patients with chronic pain to ...